NBIX- Neurocrine Biosciences, Inc.

Name: Neurocrine Biosciences, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Gano Kyle	140.4K	$23.05M	-
Other	Benevich Eric	52.8K	$8.66M	-
Other	Lippoldt Darin	46.8K	$7.68M	-
Other	Cooke Julie	39.6K	$6.51M	-36,937
Other	Onyia Jude	36.8K	$6.05M	-22,000

Activity

Buys and sells only

Transactions

10 filings · page 34

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Feb 6, 2019	Bozigian Haig P.	Chief Development Officer	Sell	920	$83.54	$76,859.38	-0.6%
Feb 6, 2019	Benevich Eric62	Chief Commercial Officer	Sell	920	$83.57	$76,883.02	-4.2%
Feb 5, 2019	Lloyd-Smith Malcolm49	Chief Regulatory Officer	Sell	1,272	$88.14	$112,118.58	-3.6%
Feb 5, 2019	Lippoldt Darin60	Chief Legal Officer	Sell	1,225	$88.09	$107,910.57	-3.3%
Feb 5, 2019	Benevich Eric62	Chief Commercial Officer	Sell	1,357	$88.01	$119,426.71	-3.6%
Feb 5, 2019	Grigoriadis Dimitri E.	Chief Research Officer	Sell	2,445	$88.14	$215,504.88	-0.7%
Feb 5, 2019	Gorman Kevin Charles55	Chief Executive Officer	Sell	7,614	$88.16	$671,216.18	-0.6%
Feb 5, 2019	Gano Kyle54	Chief Business Development Off	Sell	3,809	$88.12	$335,667.92	-1.1%
Feb 5, 2019	Bozigian Haig P.	Chief Development Officer	Sell	2,725	$88.12	$240,125.44	-0.7%
Jan 8, 2019	Roberts Eiry49	Chief Medical Officer	Sell	1,857	$84.09	$156,158.66	-37.1%

← PrevPage 34Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC